Adam Stern
Director/Board Member bij ORGANOVO HOLDINGS, INC.
Vermogen: 525 783 $ op 31-03-2024
Profiel
Adam K.
Stern is currently the Chief Executive Officer & Partner at SternAegis Ventures LLC, Independent Director at Organovo Holdings, Inc., Director at DarioHealth Corp., and Director at Aerami Therapeutics Holdings, Inc. He previously held positions such as Senior Managing Director at Augment Securities, Inc., Director at Organovo Holdings, Inc., Director at InVivo Therapeutics Corp., and Director at Matinas BioPharma Holdings, Inc. He also served as SVP & Managing Director-Private Equity Marketing at Josephthal & Co (Broker).
Stern received his undergraduate degree from the University of South Florida in 1987.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DARIOHEALTH CORP.
1.17% | 06-03-2024 | 317 250 ( 1.17% ) | 485 393 $ | 31-03-2024 |
ORGANOVO HOLDINGS, INC.
0.39% | 17-11-2023 | 39 214 ( 0.39% ) | 40 390 $ | 31-03-2024 |
Actieve functies van Adam Stern
| Bedrijven | Functie | Begin |
|---|---|---|
| DARIOHEALTH CORP. | Director/Board Member | 01-03-2020 |
| ORGANOVO HOLDINGS, INC. | Director/Board Member | 14-07-2020 |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Director/Board Member | 01-12-2014 |
SternAegis Ventures LLC
 SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures LLC (SternAegis Ventures) is a private equity/venture capital firm, a subsidiary of Aegis Capital Corp. founded in 2012. The firm is headquartered in New York. | Chief Executive Officer | 01-11-2012 |
Eerdere bekende functies van Adam Stern
| Bedrijven | Functie | Einde |
|---|---|---|
| WESTERN ACQUISITION VENTURES CORP. | Director/Board Member | 28-12-2023 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 02-11-2020 |
| HYDROFARM HOLDINGS GROUP, INC. | Director/Board Member | 01-01-2020 |
| DARIOHEALTH CORP. | Director/Board Member | 03-05-2014 |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Adam Stern
| University of South Florida | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| ORGANOVO HOLDINGS, INC. | Health Technology |
| DARIOHEALTH CORP. | Health Technology |
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| HYDROFARM HOLDINGS GROUP, INC. | Producer Manufacturing |
| WESTERN ACQUISITION VENTURES CORP. | Finance |
| Bedrijven in privébezit | 9 |
|---|---|
Augment Securities, Inc.
 Augment Securities, Inc. Investment ManagersFinance Augment Securities, Inc. (Augment Securities) is a venture capital subsidiary of Spencer Trask Holdings, Inc. founded in 1991 by Kevin Brian Kimberlin. The firm is headquartered in New York, New York. | Finance |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Health Technology |
| Josephthal & Co (Broker) | Finance |
SternAegis Ventures LLC
SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures LLC (SternAegis Ventures) is a private equity/venture capital firm, a subsidiary of Aegis Capital Corp. founded in 2012. The firm is headquartered in New York. | Finance |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Health Technology |
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Health Technology |
